Researchers identify molecule that protects women’s eggs.
A new study from the University of Gothenburg has identified the key molecule ‘Greatwall kinase’ which protects women’s eggs against problems that can arise during the maturation process. The study is published in The Journal of Cell Biology.
In order to be able to have a child, a woman needs eggs that can grow and mature. One of these eggs is then fertilised by a sperm, forming an embryo. During the maturation process, the egg needs to go through a number of stages of reductional division, called meiosis. If problems occur during any of these stages, the woman can become infertile. Around 10-15% of all women experience fertility problems, caused by factors such as genetics, environment and age.
Using genetically modified mouse models the team has now discovered that the molecule Greatwall kinase is of great importance in order for the eggs of the female mouse to be able to complete the first phase and move on to the second meiotic division during the maturation of the egg. When Greatwall kinase is removed from the egg, not all the stages can be completed. Instead, the egg enters an interphase with an abnormal DNA structure and problematic cell cycles. These problems make females infertile.
The team summise that Greatwall kinase is important in the human egg maturation process and is important in the regulation of the cell cycle. The group aims to carry out studies on human eggs as the next stage.
The team state that if they discover that there are women whose eggs do not mature due to levels of Greatwall kinase being too low, then they can inject the molecule into the egg. Hopefully, the maturation process will thereby be corrected, and eventually the woman may be able to have children, thus reversing the infertile state.
Source: University of Gothenburg
fertility, genetics, Greatwall kinase, healthinnovations, infertility, women's health
Michelle Petersen View All
I am an award-winning science journalist and health industry veteran who has taught and worked in the field.
Featured by numerous prestigious brands and publishers, I specialize in clinical trial innovation–-expertise I gained while working in multiple positions within the private sector, the NHS, and Oxford University, where I taught undergraduates the spectrum of biological sciences integrating physics for over four years.
I recently secured tenure as a committee member for the Smart Works Charity, which helps women find employment in the UK.
Loving the information on this internet site , you have done outstanding job on the articles .